 |
 Video: What is a Stock Split?
|
|
|
| BiomX is a clinical stage microbiome product discovery company developing products using both natural and engineered phage technologies designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in diseases, such as inflammatory bowel disease (IBD), liver disease and cancer. Co. is is developing BX001, its lead product candidate, to modify the appearance of skin in a range of skin types, including in oily and acne-prone skin. BX002 is Co.'s therapeutic phage product candidate designed to treat IBD. BX003 is Co.'s therapeutic phage product candidate targeting bacteria associated with primary sclerosing cholangitis, an inflammatory liver disease. According to our BiomX stock split history records, BiomX has had 0 splits. | |
|
BiomX (PHGE) has 0 splits in our BiomX stock split history database.
Looking at the BiomX stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BiomX shares, starting with a $10,000 purchase of PHGE, presented on a split-history-adjusted basis factoring in the complete BiomX stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/14/2019 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$9.65 |
|
| End price/share: |
$0.38 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-96.02% |
|
| Average Annual Total Return: |
-46.58% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$397.86 |
|
| Years: |
5.14 |
|
|
|
|
|
